Background and Purpose The gut microbial metabolite butyrate is linked to the modulation
of metabolic disease. The mechanism by which butyrate effects in atherosclerosis is …

Background: Metabolic syndrome (MS) is one of the major causes of coronary artery
diseases (CAD). Gut microbiome diversity and its natural fermentation products are not only …

Cardiovascular diseases (CVD) are major causes of death worldwide. Recently, new roles
for intestinal microbiota in pathology and treatment of CVD have been proposed. Butyrate, a …

Metabolic syndrome (MetS) and the associated incidence of cardiovascular disease and
type 2 diabetes represents a significant contributor to morbidity and mortality worldwide …

In this study, we investigated the effect of diet supplementation with sodium butyrate (5%
w/w), a short-chain fatty acid produced by the intestinal microbiota, on metabolic parameters …

Background & aims Butyrate is a four-carbon fatty acid that presents anti-inflammatory, anti-
oxidative and apoptotic properties in colon and several cell lines. Because atherosclerosis …

Butyrate, a key metabolite fermented by gut microbiota mainly from undigested
carbohydrates such as dietary fibers is widely used as feed additive. However, mechanisms …

Studies in human microbiota dysbiosis have shown that short-chain fatty acids (SCFAs) like
propionate, acetate, and particularly butyrate, positively affect energy homeostasis …

Worldwide obesity is a public health concern that has reached pandemic levels. Obesity is
the major predisposing factor to comorbidities, including type 2 diabetes, cardiovascular …

It is increasingly recognized that there is a connection between diet, intestinal microbiota,
intestinal barrier function and the low‐grade inflammation that characterizes the progression …